Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure.
Louis
Amala A
AA
Department of Academic Cardiology, Castle Hill Hospital, Cottingham, HU16 5JQ, Kingston upon Hull, UK.
Manousos
I Renata
IR
Coletta
Alison P
AP
Clark
Andrew L
AL
Cleland
John G F
JG
D000083:Acetanilides; D000787:Angina Pectoris / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D001145:Arrhythmias, Cardiac / Q000453:epidemiology / Q000628:therapy; D002309:Cardiology / Q000379:methods; D002986:Clinical Trials as Topic; D015897:Comorbidity; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D003866:Depressive Disorder / Q000188:drug therapy / Q000453:epidemiology; D004554:Electric Countershock; D005260:Female; D006333:Heart Failure / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D020108:Nicorandil / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage*; D000069458:Ranolazine; D012680:Sensitivity and Specificity
D000083:Acetanilides; D010879:Piperazines; D020108:Nicorandil; D000069458:Ranolazine